XLO - Gold Gains 1%; Walgreens Narrows Earnings Forecast | Benzinga
U.S. stocks traded slightly higher midway through trading, with the S&P 500 gaining around 0.1% on Thursday.
The Dow traded up 0.06% to 39,785.87 while the NASDAQ rose 0.06% to 16,408.04. The S&P 500 also rose, gaining, 0.13% to 5,255.09.
Check This Out: Jim Cramer Likes Crown Castle, But Can't Recommend Archer Aviation: It Has 'No Earnings Power'
Leading and Lagging Sectors
Energy shares jumped by 0.6% on Thursday.
In trading on Thursday, communication services shares fell by 0.2%.
Top Headline
Walgreens Boots Alliance Inc (NASDAQ: WBA) reported better than expected second-quarter earnings and tightened FY24 guidance.
Walgreens said second quarter fiscal year 2024 sales increased 6.3% Y/Y to $37.1 billion, up 5.7% on a constant currency basis, beating the consensus of $35.86 billion. Adjusted EPS increased 3.4% to $1.20, up 2.8% on a constant currency basis, reflecting a lower adjusted effective tax rate and improved profitability in U.S. Healthcare, beating the consensus of 82 cents, according to data from Benzinga Pro.
Walgreens Boots Alliance narrowed the fiscal year 2024 adjusted EPS guidance to $3.20-$3.35 versus prior guidance of $3.20-$3.50 and consensus of $3.24.
Equities Trading UP
Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares shot up 385% to $23.05 after the company announced it acquired a Phase 2-ready anti-IL-1β mAb, which it refers to as AVTX-009, through the acquisition of privately held AlmataBio. The company ...